Back to catalogue
№ 167 32 filings · 2021-09-13 → 2026-09-18

DIANOMI PLC

DNM
Media Share price 64.50p Market cap £19m Overall fit 210 /1000

Poor fit for the strategy: Dianomi is a victim of AI-driven traffic disintermediation, not a beneficiary; the current 64.5p price is essentially the announced cash offer and offers ~9% upside to mid fair value only via the uncertain CCU. Safe but strategically irrelevant.

Fair value range 66p–76p Mid case · £21m
Absolute upside +10% vs current market cap
Conviction 5/5 confidence in fair call
Supports the call
  • Scheme announcement with 75.3% irrevocables above 75% threshold
  • 64p cash consideration unconditional on CCU outcome
  • Price bounded by contractual deal terms, not forecasts
Limits the call
  • CMA Phase 2 risk explicitly flagged as material by Bidco
  • CCU is formulaic but genuinely uncertain — could pay zero
Methodology

M&A deal-consideration sum-of-parts (64p cash + prob-weighted CCU)

In one line · bull case

Locked-in 64p cash takeover at essentially deal price offers safe ~9% arb upside via up-to-24p contingent CCU, with 75% irrevocables and only CMA/deal-timing risk.

In one line · biggest risk

CMA Phase 2 reference lapsing the deal, sending the share back toward pre-bid 14-38p range — 45-80% downside from current.

Drivers
AI beneficiary 8 /100
Structurally exposed to AI-driven zero-click search compressing publisher traffic; adaptive product moves do not offset erosion.
Operating leverage 55 /100
Fixed cost base of £7-8m against gross profit of £7-9m gives theoretical leverage, but revenue has moved the wrong way.
Earnings vs expectations 40 /100
Mixed record — Dec 2024 warning, but Mar 2026 EBITDA beat and H1 2026 inflection; more misses than beats over three years.
Growth momentum 25 /100
Revenue declined from £35.9m to £27.4m over three years; H1 2026 modest +2% return to growth right before takeover.
Moat 25 /100
Publisher relationships and premium contextual positioning are real but narrow; churn low but pricing power limited and being eroded.
Earnings quality 55 /100
Clean IFRS reporting, adjusted vs statutory reconciliations shown; some one-offs (share-based payment credits, receivable write-off).
Management quality 45 /100
Founders sold at 350% premium to 6-month VWAP; Board explicitly chose sale over standalone execution — competent capital allocation for shareholders in the end.
Cyclicality 55 /100
Digital ad spend has cyclical sensitivity to macro conditions but is not deeply cyclical.
Leverage 5 /100
Net cash of £6.0m at Jun 2026, no debt, no facilities — fortress balance sheet for its size.
Value-trap signals · 5
  • Multi-year revenue decline £35.9m → £27.4m (2022-2025)
  • Net cash halved from £11.7m to £6.0m over ~4 years
  • Repeated guidance downgrades (Jul 2023, Dec 2024)
  • Terminal-decline exposure to AI substitution of publisher traffic
  • Board itself cited persistent AIM small-cap discount as a reason to sell

DIANOMI PLC (DNM) — Investment Research Note

Executive summary

Dianomi is a small-cap UK-listed native/contextual digital advertising platform specialising in premium finance and business publishers, whose revenue has drifted from £35.9m (2022) to £27.4m (2025) as reader traffic on non-subscription publishers has been eroded by AI-generated "zero-click" summaries 2026-05 final results. Operating trajectory over the period is one of gradual erosion at the top line, thin/negative EBITDA, and a broadening product mix (Interactive, Insights, Audiences, Dappier AI partnership) that has yet to arrest the structural pressure. The single most important valuation point is that on 18 September 2026 Taboola announced a recommended cash acquisition at 64p per share (plus a contingent 0-24p CCU) with irrevocables covering 75.3% of the register — this is now a deal-arb/M&A situation, not a fundamental one 2026-09-18 scheme announcement.

Fair value estimate

  • Fair value range: 66p – 76p per share (implied market cap £19.8m – £22.8m).
  • Methodology: sum-of-parts of the announced deal consideration: (i) 64p certain cash consideration, plus (ii) probability-weighted CCU value. The CCU pays 0–24p on a straight-line basis if Agreed Publishers reach 50–100% of a forecast revenue target under new Taboola-standard terms during a 6-month reference period. Given execution risk (publishers must voluntarily adopt Taboola's exclusivity/duration/code-on-page terms), a broker-independent estimate of 2p (bear) to 12p (base) to 20p (bull) for the CCU seems defensible; midpoint ~10-12p.
  • Standalone/fundamental value (no deal): 6× 2026E adjusted EBITDA of ~£0m plus £6m net cash ≈ £6m, or ~20p per share. Even a generous 1× EV/Sales on £27m revenue with £6m cash implies ~£33m / 110p, but this is not how a persistently loss-making, structurally declining micro-cap trades — the pre-announcement 6-month VWAP of 14.2p is the honest read of standalone value.
  • Compared to disclosed market cap of £19.4m: current 64.5p is essentially the cash offer. Absolute upside to mid-point fair value ≈ +9%; downside if deal collapses (CMA) is ~-50% to standalone value.

Sector context

ICB classification (Consumer Discretionary/Media) is confirmed. Dianomi's quality/growth/leverage profile sits well below typical Media peers — it is a sub-scale ad-tech native player being disintermediated by AI-driven traffic decline, with negative EBITDA and negligible operating leverage at current volumes. Nearest listed comparables (all much larger, higher-quality): Taboola (TBLA, the acquirer), Outbrain/Teads (OB), and at the premium end trade-desk peers like TTD. None trade at multiples that would rescue Dianomi's standalone valuation.

Investment thesis (3 bullets)

  • Locked-in cash consideration with strong shareholder support. 64p cash offer represents a 68% premium to the last unaffected close of 38p and a 350% premium to the 6-month VWAP; 75.3% of the register (directors + BGF + three named shareholders) is under irrevocable undertaking to vote in favour, well above the 75%-in-value scheme threshold 2026-09-18 scheme announcement.
  • Contingent Consideration Unit optionality. Up to 24p of additional cash per share (~37% incremental) if a subset of publishers adopt Taboola standard terms within the reference period; assessment is formulaic (no Bidco discretion) with two CCU representatives protecting holders 2026-09-18 scheme announcement, para 11.
  • Downside truncation. At 64.5p, the price sits ~0.8% above the guaranteed cash floor — small risk premium for CMA/deal-timing risk. If the deal completes on the announced timetable (end of 2026), holding period is ~3 months for effectively risk-free 64p plus lottery-ticket CCU.

Key risks (3 bullets)

  • CMA condition is material and can lapse the deal. Bidco has stated it will seek Panel consent to invoke the CMA condition and let the deal lapse if a Phase 2 reference occurs — Taboola/Dianomi assess this as low-probability but the offer document explicitly flags this as of "material significance" 2026-09-18, para 14. If the deal fails, the shares are likely to revert toward the 14–38p pre-bid range, i.e. 45–80% downside from current.
  • CCU may pay zero. Payment requires Agreed Publishers to sign New Publisher Agreements with Taboola's exclusivity/24-month-no-termination/code-on-page terms and hit ≥50% of net revenue forecast in a 6-month window; if <50%, CCU = 0. Publishers control this decision and Taboola controls Dianomi's day-to-day post-effective date 2026-09-18, para 11.
  • Structural business decline (matters only if deal fails). FY25 revenue £27.4m vs FY22 £35.9m; H1 2025 impressions -16% YoY; AI zero-click search continues to compress publisher traffic; even the improved H1 2026 (revenue +2%, gross margin 28.9%) delivered only a small EBITDA loss with net cash falling from £8.8m (Dec 24) to £6.0m (Jun 26) 2026-09 half-year, 2026-05 final results.

Operating leverage

On paper Dianomi has meaningful fixed-cost structure — administrative expenses were roughly stable at £7-8m regardless of whether revenue was £28m or £35m, so incremental gross profit should drop through. FY25 disclosed £8.3m admin expenses vs £4.3m staff costs (fixed) + IT/software £1.6m (largely fixed) — well over half the cost base scales with headcount, not revenue 2026-05 final results, note 6. Historically at £35.9m revenue in FY22, gross margin 27.3% produced £9.8m gross profit and £1.6m adjusted EBITDA; the current £27.4m revenue produces £7.4m gross profit and -£0.3m adjusted EBITDA. So on the current cost base, ~£8m of incremental revenue at 28% gross margin (£2.2m gross profit) roughly translates dollar-for-dollar to EBITDA — an operating leverage picture that would score high in the abstract. But the whole discussion is moot: (a) the business is being acquired, and (b) the direction of revenue is the wrong way for the operating leverage to matter. No score for this investor.

Value-trap signals

  • Multi-year revenue decline (£35.9m → £27.4m over three years).
  • Erosion of net cash from £11.7m (Dec 22) to £6.0m (Jun 26) despite modest headline P&L losses — reveals real cash burn once working capital reverses and one-offs are stripped out.
  • Repeated downward guidance in 2023-24 (July 2023, December 2024 profit warnings).
  • Customer/publisher concentration (CNN Business and Associated Press cited as top publishers; the CCU mechanism itself concentrates risk on a specific publisher subset).
  • Terminal-decline exposure to AI substitution in the core native-advertising business model.
  • Board recommendation explicitly cites "the environment facing small-capitalisation AIM-quoted technology companies, in which constrained liquidity and a persistent discount to intrinsic value are reflected in depressed share prices" — i.e., the Board itself is signalling a structural value trap 2026-09-18, para 5.

Earnings vs. expectations

  • FY23 trading update (Jan 2024): revenue £30.1m broadly in line, adj EBITDA loss £0.3-0.4m — a beat vs earlier consensus after H2 cost actions 2024-01-11 trading.
  • FY24 (Dec 2024 warning): revenue in line at £28m but adj EBITDA loss vs consensus small profit — a miss driven by softer US-election traffic uplift than expected 2024-12-10 trading.
  • FY25 (Mar 2026 update): revenue £27.4m broadly in line, EBITDA loss £0.3m vs consensus £1.1m loss — a beat on profitability driven by cost discipline and gross margin optimisation 2026-03-18 trading.
  • H1 2026: return to modest revenue growth (+2%, +4.5% cc) and EBITDA loss narrowed to £0.1m from £0.6m — positive inflection 2026-09 half-year.
  • Overall pattern: more misses than beats over the past three years on the top line, but recent quarters have shown better cost/margin discipline. The Board ultimately chose to sell rather than execute a standalone recovery.

Conviction: 5 — very high

  • Anchors: (i) the scheme announcement is a fully documented cash offer with signed irrevocables covering 75.3% of the register above the 75% scheme threshold; (ii) the 64p cash component is unconditional on the CCU outcome; (iii) the current price of 64.5p is essentially the cash floor, so the fair-value range is bounded by publicly-disclosed contractual terms rather than fundamental forecasts.
  • Caveats: (i) the CMA condition is a non-trivial deal-break risk that Bidco can invoke; (ii) the CCU is genuinely uncertain and could pay zero.

The view is that the shares are approximately fairly valued to slightly undervalued relative to expected deal consideration, but this is a completed-deal-arb setup, not a growth investment.

Overall score for this investor: LOW fit

This is emphatically not an AI-receiver — Dianomi is on the losing side of AI adoption (zero-click, generative summaries eroding publisher traffic). Operating leverage is theoretically present but revenue trajectory has been the wrong direction. Valuation offers ~9% upside to mid fair value with a hard cash floor at 64p, so downside protection is genuinely good. However, this is a deal-arb trade with a ~3-month duration, not a portfolio position aligned with the investor's three pillars. Score reflects the poor strategic fit despite the safe near-term price.

Filings consulted · 32

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-09-18Recommended Acquisition OF Dianomi Plc2026-09-18_9778532_recommended-acquisition-of-dianomi-plc.md0.75
  2. 2026-09-07Half Year Financial Report2026-09-07_9757536_half-year-financial-report.md0.90
  3. 2026-07-27Trading Update2026-07-27_9687603_trading-update.md0.85
  4. 2026-06-25Result OF Agm2026-06-25_9637395_result-of-agm.md0.30
  5. 2026-06-02Notice OF Agm2026-06-02_9596026_notice-of-agm.md0.30
  6. 2026-05-29Final Results2026-05-29_9590881_final-results.md1.00
  7. 2026-03-18Trading Statement2026-03-18_9479234_trading-statement.md0.72
  8. 2025-09-24Half Year Report2025-09-24_9127411_half-year-report.md0.77
  9. 2025-06-26Result OF Agm2025-06-26_8949807_result-of-agm.md0.20
  10. 2025-05-23Notice OF Agm2025-05-23_8893766_notice-of-agm.md0.20
  11. 2025-05-19Final Results2025-05-19_8883818_final-results.md0.65
  12. 2024-12-10Trading Statement2024-12-10_8600353_trading-statement.md0.55
  13. 2024-09-23Half Year Report2024-09-23_8431105_half-year-report.md0.58
  14. 2024-07-18Trading Statement2024-07-18_8318092_trading-statement.md0.38
  15. 2024-05-31Result OF Agm2024-05-31_8235144_result-of-agm.md0.14
  16. 2024-05-08Notice OF Agm2024-05-08_8182493_notice-of-agm.md0.14
  17. 2024-05-01Final Results2024-05-01_8165793_final-results.md0.45
  18. 2024-01-11Trading Statement2024-01-11_7984405_trading-statement.md0.38
  19. 2023-09-20Half Year Report2023-09-20_7765933_half-year-report.md0.23
  20. 2023-07-17Trading Statement2023-07-17_7635572_trading-statement.md0.21
  21. 2023-06-01Result OF Agm2023-06-01_7554207_result-of-agm.md0.07
  22. 2023-05-05Notice OF Agm2023-05-05_7514293_notice-of-agm.md0.07
  23. 2023-04-20Final Results2023-04-20_7467247_final-results.md0.25
  24. 2023-02-02Trading Statement2023-02-02_7352662_trading-statement.md0.21
  25. 2022-12-13Trading Statement2022-12-13_7407017_trading-statement.md0.21
  26. 2022-09-21Half Year Report2022-09-21_7415089_half-year-report.md0.23
  27. 2022-07-18Trading Statement2022-07-18_7034815_trading-statement.md0.21
  28. 2022-06-01Result OF Agm2022-06-01_7108291_result-of-agm.md0.07
  29. 2022-05-09Posting OF Annual Report And Notice OF Agm2022-05-09_7240448_posting-of-annual-report-and-notice-of-agm.md0.24
  30. 2022-05-04Final Results2022-05-04_7145573_final-results.md0.25
  31. 2022-01-26Trading Statement2022-01-26_6953033_trading-statement.md0.21
  32. 2021-09-13Interim Results2021-09-13_6823601_interim-results.md0.09

This research note was authored by a large language model after reading 32 regulatory filings published between 2021-09-13 and 2026-09-18. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.